HUMAN CAPITAL MANAGEMENT

(MM6011)

“Healthcare Industry: Proposed New Competency Model to be

Implemented at Bio Farma in Industry 4.0”

BY:

Lilifly 29118113
Amirus S. Mejaya 29118081
M. Luhur Istighfar 29118099
Ruth Damayanthi P. 29118064

Master of Business Administration

Institut Teknologi Bandung
2019
 CONTENTS

CHAPTER 1 Introduction.................................................................................................................... 3
1.1 Company Profile.....................................................................................................................3
1.2 Business Problem................................................................................................................... 5
1.3 Research Objective.................................................................................................................5
1.4 Methodology.......................................................................................................................... 5

CHAPTER 2 Study Literature..............................................................................................................7

2.1 Industry 4.0.............................................................................................................................7
2.2 Industry of Healthcare............................................................................................................ 7
2.3 Impacts of Application Industry 4.0 in Healthcare Industry.................................................. 8
2.4 Challenges in Implementing 4.0 in Healthcare Industry........................................................9

CHAPTER 3 Analysis........................................................................................................................10
3.1 Core Competencies in Healthcare Industry..........................................................................10
3.2 Functional Competencies in the Healthcare Industry.......................................................... 10
3.3 Managerial Competencies in Healthcare Industry............................................................... 11
3.4 Propose New Job Position..........................................................................................12

CHAPTER 4 Recommendations and Conclusion..............................................................................15

4.1 Recommendations................................................................................................................ 15
4.2 Conclusion............................................................................................................................19

REFERENCES...................................................................................................................................20
APPENDIX........................................................................................................................................ 21
 CHAPTER 1
Introduction

1.1 Company Profile

Bio Farma is a state-owned company that produces vaccines and serums to
support immunization in Indonesia and other countries. The Bio Farma company,
located in Bandung, has been included in the World Health Organization (WHO)
pre-qualification list. Bio Farma produces two kinds of vaccines, namely viruses
and bacteria. The virus vaccine produced by Bio Farma consists of the measles
vaccine, polio oral vaccine, and hepatitis B, while the bacterial vaccine that has
been produced is the DTP TT vaccine, DT vaccine, and BCG vaccine.
With more than 125 years of experience and competence, Bio Farma always
innovates while still referring to international standards and the latest quality
management system. Throughout its journey, Bio Farma has undergone various
changes in the legal entity in following the changing times. The establishment of
Bio Farma began with the establishment of Parc Vaccinogene on 6 August 1890
(based on the Decree of the Governor of the Netherlands East Indies Number 14 of
1890). Parc Vaccinogene, located in the pavilion of the Weltevreden Military
Hospital, Batavia (currently the Gatot Soebroto Army Central Hospital, Jakarta),
pays great attention to the health sector. The institute has conducted various studies
in helping to eradicate infectious diseases. In conducting research on microbiology,
Parc Vaccinogene collaborated with the Pasteur Institute, so the institute changed its
name to Parc Vaccinogene en Instituut Pasteur.
Through Government Regulation No. 80 of 1961 (Statute Book of 1961
No.101), this institution was officially changed into the Bio Farma State Company.
And in 1997, it officially changed to PT Bio Farma (Persero). Until now, Bio Farma
has always been committed to prioritizing research and research, because they
realize its important role in building the nation's health. The company continues to
collaborate with various national and international research institutes in technology
transfer, which makes Bio Farma one of the few world vaccine manufacturers that
meets WHO qualifications, so it is trusted to meet vaccine needs in more than 122
countries. Bio Farma has also received CPOB (Good Manufacturing Practices)
certification from the Food and Drug Monitoring Agency (BPOM), Quality
Management System ISO 9001: 2008, ISO 14001: 2004, and OHSAS 18001: 2007.

1.1.1 History of PT Bio Farma (Persero)

PT Bio Farma (Persero) is a government-owned company that is the
only vaccine manufacturer for humans in Indonesia, and is one of the largest
in Southeast Asia. Bio Farma has always dedicated itself to producing high-
quality vaccines and serums, with the aim of supporting the national
immunization program. This is done by Bio Farma to create a healthy
Indonesian society. The beginning of the establishment of Bio Farma began
in 1890 and continues to develop until now. The history of the establishment
 of Bio Farma is stated in the following information:
 August 6, 1890, Bio Farma was established under the name "Parc
Vaccinogene" on August 6, 1890 based on the Decree of the Governor of
the Netherlands East Indies Number 14 of 1890 at the Military Hospital
Weltevreden, Batavia which has now changed its function to become the
Central Army Hospital Gatot Soebroto (Gatot Soebroto Army Hospital),
Jakarta.
 1895 - 1901, the Company changes its name to "Parc Vaccinogene en
Instituut Pasteur".
 1902 - 1941, the Company again changes its name to "Landskoepoek
Inrichting en Instituut Pasteur". In 1923, Bio Farma began occupying the
location on Jalan Pasteur No. 28 Bandung led by L. Otten.
 1942 - 1945, During the Japanese occupation, Bio Farma was renamed
"Bandung Boeki Kenkyushoo" led by Kikuo Kurauchi.
 1945-1946, the Company changes its name again to "Smallpox Building
and Pasteur Institution". The company is led by R. M. Sardjito who is the
first Indonesian leader. During the leadership of R. M. Sardjito, the
location was moved to the Klaten area.
 1946 - 1949, During the Military Aggression, when Bandung was again
occupied by the Dutch. The company changed its name again to
"Landskoepoek Inrichting en Instituut Pasteur".
 1950 - 1954, the Company changed its name again to "Smallpox
Building and Pasteur Institution" which is one of the departments within
the Ministry of Health of the Republic of Indonesia.
 1955 - 1960, During the nationalization of ownership of Dutch
companies in Indonesia. The company then changed its name back to
"Pasteur State Enterprise". The company is better known by the name PN.
Pasteur
 1961 - 1978, the Company changed its name again to "Bio Farma State
Company" or better known as PN. Bio Farma.
 1978 - 1996, Based on Government Regulation No. 26 of 1978, the
company changed its name to the Bio Farma Public Company, better
known by the name Perum Bio Farma.
 1997, Based on Government Regulation No. 1 of 1997, the company's
name changed again from Perum Bio Farma to a Company Company
(Persero) or better known by the name PT Bio Farma (Persero) until now.

1.1.2 Philosophy, Vision, and Mission

Philosophy : Dedicated to Improve Better Quality of Life.
Vision : To Become a World Class Life Science Company with
Global Competitiveness.
Mission : Provide and Develop Life Science Products of International
Standards to Improve the Quality of Life
 1.1.3 Values And Policy Of The Company
Corporate Values
Each Corporate entity behaving and thinking professionally, possesses high
integrity, functioning as a team, with full innovation and customer service
oriented.
 Professional
Committed in carrying out tasks with full responsibility, efficiency,
effectiveness, thinking ahead and abiding with the procedures.
 Integrity
Honest, transparent and trustworthy in accordance with the objectives
of the Company.
 Teamwork
Working together by appreciating the role and opinions of others.
 Innovation
Making continuous improvements and developments in creating new
ideas.
 Customer Oriented
Understanding the needs of customers and providing appropriate
solutions.

1.2 Business Problem

Based on the results of interviews we conducted with representatives of Bio
Farma, the health industry in Indonesia still seems to lack professional professionals
who master the processing, grouping and utilization of data. Though many things
can be found from these data. Where, these data can be utilized to improve the
effectiveness and efficiency in the company.

1.3 Research Objective

This research was conducted with the aim of proposing new positions or
positions that could help resolve or alleviate the problems currently being faced by
the company, where in this case BIo Farma. The existence of this new position is
expected to help improve the effectiveness and efficiency in the company.

1.4 Methodology
This study uses explorative qualitative methods that aim to find out the
process or understanding in depth by conducting research to informants to be
investigated. Data collection techniques were carried out using a purposive method,
where informants were determined based on criteria related to the research problem.
The informants used came from two similar programs. Data collection using
interview and observation techniques. The results of this study are to find out
whether or not Bio Farma is a player in the healthcare industry in Indonesia in the
industrial era 4.0, formed a new position based on existing competencies and new
competencies.
 The data analysis method that the researchers used was a descriptive
qualitative analysis method according to Miles and Huberman Models (Sugiyono,
2012) which consisted of three stages. The first stage is data reduction, which starts
with finding and collecting interviews and observations related to the company.
Data collected by researchers from these sources will be grouped and the checking
process is carried out through triangulation of data to be re-selected based on the
needs and suitability of the study, so that data that is not needed will be sorted /
discarded. The next step is to simplify the data / research results so that the data is
easily understood and presented easily. The second stage is the presentation of data
which is done by categorizing and compiling a collection of data / information to
get a complete and systematic picture to facilitate drawing conclusions and taking
action. Presentation of data used in this qualitative study is narrative text, both in
the form of brief descriptions, charts, tables, relationships between categories, and
flowcharts that are easy to understand. The third stage is drawing conclusions.
 CHAPTER 2
Study Literature

2.1 Industry 4.0

The industrial revolution 4.0 is the fourth industrial era since the first
industrial revolution in the 18th century. Industrial era 4.0 is characterized by a
blend of technology that blurs the boundaries between the physical, digital and
biological fields, or collectively referred to as the cyber-physical system.
In addition, the fourth industrial revolution era was also marked by the
emergence of technological breakthroughs in a number of fields. The fields in
question include the fields of robotics, artificial intelligence, nanotechnology,
quantum computing, biotechnology, internet of things, the internet of things industry,
fifth generation wireless technology (5G), additive manufacturing / printing 3D and
3D fully autonomous vehicle industries.
These technologies are changing the order of almost every industry in every
country. The extent of this change marks the transformation of the entire production,
management and government system. The fourth industrial revolution is expected to
see a large implementation of some emerging technologies with high potential for
change effects.

2.2 Industry of Healthcare

2.2.1 Health before Industry 4.0
Before the existence of industry 4.0, the health service situation
could still be done traditionally. This is indicated by health services that are
still limited so that health services become less efficient. In addition, before
this 4.0 industry era, health workers were still not optimal in meeting the
various needs of patients. The following are some sections in the field of
health care before succeeding 4.0:
1. Medical personnel who work less efficiently in meeting the needs of
patients in the area, where they still have difficulty assessing vital signs
and reading biometrics and electrocardiogram readings.
2. There is no health application that can make it easy for patients, where
need to visit health, patients must come to the nearest hospital or clinic.
3. In addition, medical staff have not been effective in their efforts to
improve public health, because there are still manual methods to be
carried out.
4. In the world of special surgical implant placement, it is still done using
2D technology which is still limited in agreement, especially for patients
with facial asymmetry.
5. In the field of medicine, having computational resources in silico that
helps the search for new medicines by developing more than three
renewal molecules and is a very effective strategy for developing new
drugs.
 6. Consultation for disease diagnosis, prognosis, and treatment is not
complete and complete with the modern era of genomic medicine
because this method is a derivative derived from reductionist analysis
and the principle of experimentation which has been successful for
decades and is good for the medical world.

2.2.2 Healthcare After Industry 4.0

Digital technology can provide convenience in various fields of life
today, one of which is healthcare. Digital development in health services
continues to progress with various adjustment processes. Digitalization in
the health sector has always had a primary focus on improving patient safety
and better health services. Some of the effects of industry 4.0 on the
healthcare industry are:
1. The availability of 24-hour online health services that can provide
maximum health services.
2. More optimal and effective health services with the 24-hour online
technology.
3. Health workers find it easier to do their work in remote areas more
effectively, for example patient monitoring programs are carried out to
help assess vital signs and record biometric readings and
electrocardiograms
4. The availability of various applications on smartphones that can help
increase public awareness of health. This application is also useful in the
initial identification of health problems that arise, enabling immediate
health interventions, thereby reducing emergency and inpatient visits
5. The application of industry 4.0 in health care is referred to as "Health
4.0". This is done with the aim to focus more on patients in hospitals or
clinics, where the function is to optimize and adjust treatment for better
clinical outcomes, and to stabilize the health care system.
6. In addition, technology-based health services can use several capabilities
to optimize patient satisfaction.

2.3 Impacts of Application Industry 4.0 in Healthcare Industry

The application of Industry 4.0 in the healthcare industry has two impacts:
negative and positive. The thing that must be noted is the negative impact must be
immediately sought a solution so that it can be a positive impact on health services,
because the technological advances that occur we can not weir the flow. Positive
and negative impacts of implementing 4.0 on health services:
1) Cost savings in the long run even though at first the costs incurred were quite
high. For example, a recent analysis based on short-term data found that two
new CAR-T cancer therapies, Kymriah (Novartis) and Yescarta (Gilead),
which each had a one-time fee of $ 475,000 and $ 373,000, respectively, were
relatively lower. against standard chemotherapy treatments.
2) Industry 4.0 can accelerate change while creating new opportunities. But
technology can also pose a risk of reducing labor in the health industry.
 3) Biotechnology will also revolutionize health and medicine, but also increase
the possibility of ethical, legal and social challenges.
4) Evaluation is needed on the use of all health professional devices, where each
technology used must be examined based on its evidence, how digital
language processing, virtual reality is then evaluated and discussed, including
how the use of this technology can change health services from the
perspective of the patient.
5) The benefits of implementing new technologies must be felt by all parties,
even though the costs incurred are quite large, so the most important thing to
consider is access and affordability. For example, the main reason for the
increase in the cost of health services in the US, which has spent 17% of GDP
or nearly $ 3 trillion on health services. According to the November 2013
issue of the Journal of the American Medical Association (JAMA), the
increase in price of medicines, medical equipment and hospital care
accounted for 91% of the increase in health care costs from 2000 to 2011. So
the 4.0 industrial revolution in the application of health technology needs to
be considered very mature.

2.4 Challenges in Implementing 4.0 in Healthcare Industry

The application of technology requires careful strategic thinking, not only to
adapt to change but also to promote it in a patient-centered way. Socio-cultural and
economic aspects include dimensions that must be considered, where appropriate
technology must implement methods that are resource-efficient, easy to maintain,
and have minimal pollutant impact compared to mainstream technology, which
generally emits a lot of waste and pollutes the environment. In addition, skill
upgrading is needed, because if this is not done then technology will erode human
resources.
 CHAPTER 3
ANALYSIS

3.1 Core Competencies in Healthcare Industry

Today, the times have progressed due to the very advanced technological
advancements. In overcoming this, every area of ​ ​ life requires large companies
in need of a system that they will use. Likewise with the health sector. The health
sector must discuss a system that can prepare health professionals. In this case
several core competencies are needed that must be approved, namely:
a. Regarding patient-centered care - considering, respecting, and caring about the
differences, values, preferences, and needs that support patients; ease pain and
suffering; coordinate ongoing care; listen, speak clearly, communicate with, and
educate patients; Share decision making and management; and continuously
discuss disease, health, and promotion of healthy lifestyles, including a focus on
population health.
b. Work in interdisciplinary teams - work together, collaborate, communicate, and
integrate care in teams to ensure that care is sustainable and reliable.
c. Promoting evidence-based practice - integrating the best research with clinical
expertise and patient values ​ ​ for optimal care, and agreeing on learning and
research activities is increasing.
d. Propose quality improvement - address problems and hazards in care; discuss
and apply basic safety design principles, such as standardization and
simplification; continuously consider and measure the quality of care in terms of
structure, process and results in considering it with the needs of patients and the
community; design and test interventions to change the process and system
maintenance, with the aim of improving quality.
e. Utilizing information - communicating, managing knowledge, reducing
problems, and supporting making decisions using information technology.

3.2 Functional Competencies in the Healthcare Industry

Today, every industry is demanded to move towards industry 4.0, where
technology and information have increasingly advanced. This also happens in the
helathcare industry, where the industry has experienced changes in the health
informatics field. Researchers and scientists are given the freedom to improve
public health, the health care system and the biomedical field. The main purpose of
this health informatics is to provide complete information about patient health to
existing health professionals.
To achieve this, the healthcare industry requires the development of
technological capabilities that can be used to study various computing tools in
analyzing large biological databases. The results of this analysis will be used to
understand the disease and these predictions are useful for dealing with health care
data. The development of this technology will direct the helathcare industry towards
tailored treatment, which uses the patient's genetic makeup to decide on the right
 drug for patients. Therefore, the healthcare industry needs some functional
competence for their professionals, such as:
 Able to operate software related to computational molecular biology
 Familiar and comfortable with the use of computer technology in work related
to biological frameworks, genetic engineering, and gene editing in drug
discovery.
 Having the ability to run and produce software that can show information that
can decipher biological and genomic information.
 Able to carry out an analysis of the genetic basis of the organism and prediction
of protein structures using crystallographic tools.
 Can use a basic local alignment search tool (BLAST) that is used to compare
the sequence of proteins, nucleotides, DNA and RNA. Because, related to the
use of identification of the sequence of a biomolecule such as nucleic acids or
proteins.
 Has the ability to carry out phylogenetic analysis using molecular evolutionary
genetic analysis (MEGA).
 And able to predict the structure and function of early-stage proteins using X-
Ray crystallography or NMR.

3.3 Managerial Competencies in Healthcare Industry

Building collaborative relationships was rated as the most important quality
needed for effective managerial operation. Partnerships and collaborations are the
rule rather than the exception they once were in the pharmaceutical sector.
Companies are looking for leadership that can leverage relationships across industry,
government, healthcare professionals, and patients. Building collaborative
relationships is a key competency to thriving in this new environment.
1) Building a collaborative relationship, how every employee must be able to work
together in any kind of environment and situation to achieve goals.
2) Analytical Skills, are the thought processes required to evaluate information
effectively.
3) Analytical skills are the ability to visualize, gather information, articulate,
analyze, solve complex problems, and make decisions.
4) Research Skills, research skills can be from need to be able to use reliable
sources for continuous learning in changing environments. Being able to
provide in depth information and advice on a given topic is an important skill.
The most successful people tend to develop research skills early and use them
consistently.
5) Entrepreneurial Skills, refer to the ability to identify marketplace opportunities
and discover the most appropriate ways and time to capitalize on them. It is
more like a state of mind that opens your eyes to new opportunities.
6) Decision Making, Decision making is the process of making choices by
identifying a decision, gathering information, and assessing alternative
resolutions. Decision making is an integral part of modern management.
Essentially, Rational or sound decision making is taken as primary function
of management. According to the Oxford Advanced Learner’s Dictionary the
 term decision making means – the process of deciding about something
important, especially in a group of people or in an organization.

3.4 Propose New Job Position

As the representative of Biofarma was mentioned about the need of
employees whom are would be had to deal with the usage of data and technology
especially for research and development (R&D) as the player within healthcare
industry need to be more efficient in terms of cost of R&D yet they had to produce
quality and better product and service for their customers. It might be able to
acquire with maximizing the usage of technology and data through Bioinformatics.
Bioinformatics is the combination of health information, data and
knowledge. It uses computational techniques and tools to analyze the enormous
biological databases. The diseases such as metabolic disorders, urea cycle disorders,
inborn errors and path-aligner can be identified at an early stage using various
bioinformatics computational tools. The aim of bioinformatics is to give path to big
data generated by molecular biology technology.
Bioinformatics is an integrative field that creates procedure and software
tools for demonstrating biological information and frameworks which are ordinarily
described by a lot of information. Bioinformatics is the mix of different fields like,
software engineering, computer science, statistics, informatics and engineering
which assess and outline biological and genomic information. The field of
Bioinformatics covers the examination of molecular data to quantifying clinical,
imaging and diagnostic data for customized medication and healthcare.
There are various applications of Bioinformatics in healthcare industry, but
we chose for specific purpose only as this field has not popular or has not
implementing yet within healthcare industry in Indonesia as follows:

3.4.1 Drug Discovery and Designer

The bioinformatics tools are used in drug discovery based on
molecular disease. Based on the disease and diagnosis management the
scientist will develop the medicines and drugs which can suits more than
500 genes. The delivery of specific drug is depending on the cells to be
targeted and various computational tools used. The aim of the computational
tools is to provide the information about portrayal of qualities, phylogenetic
examinations, deciding auxiliary and physiochemical properties of proteins.
This information is useful to think about the behavior of biomolecule in a
living cell.
Before inventing the bioinformatics tools, the researchers belongs to
various fields such as pharmacology, clinical sciences and chemistry worked
together for introducing the new compound to the world. The invention of
the bioinformatics stops the above procedure and encouraged the revelation
and planning in the medical field. It is easy to break down the molecules
using the software compared with various practice approaches. The
advances in the software design and information technology leads to
discover the computer aided drug design (CADD) to design highly effective
drugs. The popular drug databases developed by various organizations to
facilitate the researchers and scientists who are interested to design the new
drug is as follows:
 Potential Drug Target Database (PDTD)
 Therapeutic Target Database (TTD)
 (TDR) Target Database
 Manually Annotated Targets and Drugs Online Resource (MATADOR)
 Drug Bank
 Tropical Disease Research
 Tuberculosis (TB) Drug Target Database
The various molecular dynamic tools such as Abalone, Ascalaph,
Discovery studio, Amber, FoldX, are used to get the information related to
ion transport, conformational changes of proteins, nucleic acids and
complexes occurring in biological systems.

Job Description
Job Code : 30082019
Job title : Drug Designer
Job Summary : Biofarma’s Drug Designers are part of R&D function
which only could be entered by passing several
internal training and development program
(Biofarma’s Management Trainee) or by
experienced professional within Molecular Biologist
which would act as the “designer” and “hacker” of
the development in virus and bacteria research that
would leading Biofarma towards customized
medicine serum producers in future, which utilizes a
patient's genetic makeup to decide the correct drug
for the currently typical disease of Indonesia and
across the world in the future.
Job Status : Full Time
Supervision : Direct Reports to R&D Manager
Competencies :
1) Biology Molecular/Microbiology
By understanding Biological Molecular and Microbiology, they
would understand multiple gene expression measurement is using
to uncover the DNA chip consists thousands of nucleotide
fragments in thousands. It will produce DNA array in large scale
and tools to build positions of protein coding areas.
2) Technological Savvy
The advances in the software design and information technology
leads to discover the computer aided drug design (CADD) to
design highly effective drugs, The competency can be acquired by
passing several levels of internal or external training.
Job Requirements:
 Male/Female with maximum age 27 years old
 Candidate must possess at least a Bachelor Degree from reputable
university in Indonesia or abroad within Molecular Biology,
Micro Biology, Biology, Pharmacy, Chemical Engineering.
 Candidate must have at least two years experiences in related field
 Proficient in English. TOEFL Score 550, IELTS Score 7 in
average
 Good knowledge of drug, virus, and/or bacteria
 Proficient in operating computer, or any related technology and/or
in data analytic are preferable
 Willing to relocate
 Strong in research, written, and analytical skills
 Ability to work in both team and individually
 CHAPTER 4
Recommendation and Conclusion

4.1 Recommendations:
Based on our research and interview with a representative of Bio Farma, we
propose for the company to form a new, specific role that meets their urgent needs
in industry 4.0 era, dubbed as “Drug Designer” (working title). So HRIS is needed
as an administration mechanism and a means of evaluation at the end of the day. As
we are proposing a new position with new competencies added, to be effective,
efficient, and fast, we need to propose training processes to our employees, both
new and existing. That is why we also create a training module which regulate
training practices.

4.1.1 Human Resources Information System “Drug Designer”

Employee Information

Name Amirus S. Magenta Liliflee

D.O.B. New Seoul/June 27th, 1998 Ujung Pandang/March 19th, 1992

Sex Male Female

Marital Single
Married
Status

Nationality South Korean Islam

Religion Christianity Indonesia

Address Jl. Gelap Nyawang 9 ¾ Jl. Pelesiran 84/58

Contact 0987654321 085341978883

Number

Email HR_Ceria@rocketmail.com liliflee@gmail.com

Blood Type AB- O+

Latest Bachelor in Pharmacy Master Degree in Biology

Education

Experience Fresh Graduate/New

Existing Employee/Microbiologist
Status Employee
Performance

Name Amirus S. Magenta Liliflee

Training Level Basic Intermediate

Certification - Microbiology analyst and Data analyst

Absent 30 January 2020 -

Research
Apotoxin 4869 Drug metabolizing enzymes
Object

Credit 96 points 385 points

Compensation
IDR 5,589,789 IDR 25,683,567
and Benefit

Evaluation - High

Technical

Indicator Level 1 Level 2 Level 3 Level 4

Free lunch,
Lunch, breakfast,
Facility Lunch Lunch breakfast, and
and coffee break
coffee break

Accomodati
- - Transportation Transportation
on

Trainers
IDR
Compensati IDR 15.000.000 IDR 30.000.000 IDR 30.000.000
10.000.000
on/Trainer

Total
4 4 3 3
Trainers

Laboratory A Laboratory B Laboratory B

Ballroom with with 30 with 15 with 10 capacity,
100 capacity, capacity, capacity, laboratory
Equipment projector, laboratory laboratory equipment,
sound system, equipment, equipment, computer,
props. computer, computer, projector,
projector, projector, biology sample.
 biology sample. biology sample.

Cost IDR
IDR 60.000.000 IDR 90.000.000 IDR 90.000.000
40.000.000

4.2.2 Training Module for Drug Designer

There are four levels of training module for drug designer, as follows:
1) Basic level
2) Elementary level
3) Intermediate level
4) Advanced level
 Basic Level of Drug Designer

Objectives : Mastering Basic software of Microbiology and Molecular

Biology
Training Method : In Class Training
Total of Trainers :4
Trainee Total : 20 (max)
Training Hours : 8 Hours per week (2 Hours per session)
Venue : Laboratory, Class, Meeting Room, Computer Room
Facility : Projector, Desk, Table, AC, Snack, Computers, Sound
System, Internet Connection, Printed Module
Credit Total : 100
Duration : Within 3 months
Subjects : Basic Local Alignment Search Tool (BLAST)

Elementary Level of Drug Designer

Objectives : Mastering the process product development and innovation

by using Basic Local Alignment Search Tool (BLAST) and
making Potential Drug Target Database (PDTD)
Training Method : In Class Training, Laboratory, Computer Lab
Total of Trainers :4
Trainee Total : 20 (max)
Training Hours : 12 Hours per week (2 Hours per session)
Venue : Laboratory, Class, Meeting Room, Computer Room
Facility : Projector, Desk, Table, AC, Snack, Computers, Sound
System, Internet Connection, Printed Module, BLAST
software
Credit Total : 100
Duration : Within 3 months
Subjects : Basic Local Alignment Search Tool (BLAST), Drug Target
Database (PDTD)

Intermediate Level of Drug Designer

Objectives : Having the ability to predict the structure and function of

proteins using X-Ray crystallography or NMR.
Training Method : In Class Training, Laboratory, Computer Lab
 Total of Trainers :3
Trainee Total : 20 (max)
Training Hours : 12 Hours per week (2 Hours per session)
Venue : Laboratory, Class, Meeting Room, Computer Room
Facility : Projector, Desk, Table, AC, Snack, Computers, Sound
System, Internet Connection, Printed Module, BLAST
software
Credit Total : 100
Duration : Within 3 months
Subjects : CATH, RAPTORX, JPRED, PHD, HMMSTR,
MODELLER, PHYRE

Advanced Level of Drug Designer

Objectives : Can find computer-aided drug design (CADD) using a

popular drug database.
Training Method : In Class Training, Laboratory, Computer Lab
Total of Trainers :3
Trainee Total : 20 (max)
Training Hours : 12 Hours per week (2 Hours per session)
Venue : Laboratory, Class, Meeting Room, Computer Room
Facility : Projector, Desk, Table, AC, Snack, Computers, Sound
System, Internet Connection, Printed Module, BLAST
software
Credit Total : 100
Duration : Within 3 months
Subjects : Potential Drug Target Database (PDTD), Therapeutic
Target Database (TTD), (TDR) Target Database, Manually
Annotated Targets and Drugs Online Resource
(MATADOR), Drug Bank, Tropical Disease Research,
Tuberculosis (TB) Drug Target Database

4.2 Conclusion
To be able to survive in Industry 4.0, Bio Farma as one of the leading
pharmaceutical companies in the healthcare industry need to be improved,
particularly from their human capital aspect. One of the ways is to improve
competencies and create new job position which can answer to the demands of
Industry 4.0 in the pharmaceutical sector. Bio Farma are expected to provide the
best products and service, not only for Indonesian people, but also the rest of the
world in the near future.
 REFERENCES

Grzybowska, Katarzyna. (2017). Key Competencies for Industry 4.0. ResearchGate.

http://www.biofarma.co.id/wp-content/uploads/Company-Profile-
Biofarma.compressed.pdf

https://www.hr40.digital/en/what-type-of-competencies-will-industry-4-0-require/

https://www.ncbi.nlm.nih.gov/books/NBK221519/

https://www.pubinfo.id/instansi-346-biofarma--pt-bio-farma-persero.html

http://bce.unpad.ac.id/pt-bio-farma/
 APPENDIX

Appendix 1 - Bio Farma Bandung

Appendix 2 - Interviewees from R&D of Bio Farma Bandung

 Appendix 3 - Handout Interview

Waktu: 12 September 2019

Tempat: Bio Farma Bandung

Narasumber:R&D of Bio Farma Bandung

Industri Kesehatan
1. Sebagai salah satu pelaku industri kesehatan di Indonesia, dapatkah anda memberikan
gambaran umum mengenai industri ini di Indonesia? Terutama perkembangan, tantangan,
dan rencana kedepan
2. Apakah bisa anda menjelaskan bagaimana peran dan keterlibatan pemerintah Indonesia
pada umumnya dan Kementrian Kesehatan/Kementrian Perindustrian/BUMN pada
khususnya pada Industri Kesehatan di Indonesia?
3. Bisakah anda sebutkan dan jelaskan 3 isu utama yang terkait mengenai SDM dalam indutri
ini? Apakah sudah ada penyelesaianya?
4. sebagai salah satu pelaku industri kesehatan di Indonesia, apa sajakah harapan anda
kedepanya terkait SDM dalam industry ini?
5. Dapatkah anda memberi pandangan mengenai kelebihan dan kekurangan perusahaan-
perusahaan kesehatan di Indonesia dibandingkan perusahaan-perusahaan asal luar negeri
terkait SDM nya?

Industri 4.0
1. Dapatkah anda memberikan gambaran umum sudah sejauh mana implementasi konsep
industry 4.0 dalam industry kesehatan di Indonesia? Bagaimana implementasinya sendiri di
perusahaan anda?
2. Sejauh apa dan apa saja keterlibatan pemerintah dalam inisiasi industry 4.0 dalam industry
kesehatan di Indonesia? Terkait SDM, apakah harapan-harapan anda kepada pemerintah
terkait industry 4.0?
3. Menurut anda SDM seperti apakah yang menurut anda yang dapat menjawab tantangan
industry 4.0 kedepanya? Apa saja kendala untuk mendapat SDM terbaik di industry ini dan
perusahaan anda?
4. Adakah langkah-langkah yang akan, sedang, atau sudah dilakukan untuk mempersiapkan
SDM terbaik yang dapat sesuai dengan industry 4.0
5. Terkait SDM, bisakah anda sebutkan kekurangan dan kelebihan SDM yang kita miliki di
industry ini dibandingkan dengan SDM yang dimiliki perusahaan-perusahaan luar negeri di
industry sejenis dalam pengimplementasian industry 4.0?
 Perusahaan/HR Strategic

1. Bagaimanakah perusahaan anda mendapatkan kandidat-kandidat pekerja terbaik di

perusahaan anda? Kandidat seperti apakah yang anda harapkan untuk dapat menjawab
tantangan industry 4.0 ini?
2. Terkait karyawan yang masih sedang bekerja, apa sajakah langkah-langkah yang
perusahaan anda lakukan untuk mempersiapkan mereka bersaing di industry 4.0?
3. Apakah pengembangan SDM terkait industry 4.0 di perusahaan anda sudah bagus
menurut anda? Apabila ada yang masih dapat dilakukan, apa yang seharusnya dilakukan?
4. Adakah posisi, jabatan, atau departemen yang menurut anda harus ada di perusahaan
anda terkait industry 4.0? Mengapa?
5. Adakah posisi, jabatan, atau departemen yang kompetitor (local atau internasional) anda
sudah miliki yang menurut anda juga dapat di adopsi oleh perusahaan anda dalam
industry 4.0?

Kompetensi/Individu

1. Untuk posisi, jabatan, atau departemen yang telah disebutkan diatas, knowledge apakah
yang harus mereka miliki? Mengapa?
2. Untuk posisi, jabatan, atau departemen yang telah disebutkan diatas, skill apakah yang
harus mereka miliki? Mengapa?
3. Untuk posisi, jabatan, atau departemen yang telah disebutkan diatas, attitude apakah
yang harus mereka miliki? Mengapa?
4. Sebutkan perusahaan kompetitor (lokal dan internasional) yang menurut anda memiliki
kandidat-kandidat terbaik di era industry 4.0 ini? Mengapa?
5. Apakah harapan anda kepada kandidat-kandidat tersebut terkait industry 4.0? Sejauh
mana mereka dapat membantu perusahaan anda bersaing di era industry 4.0?